
1. malar j. 2015 aug 22;14:328. doi: 10.1186/s12936-015-0850-9.

chloroquine sensitivity: diminished prevalence chloroquine-resistant gene
marker pfcrt-76 13 years cessation chloroquine use msambweni, kenya.

kiarie wc(1)(2), wangai l(3), agola e(4), kimani ft(5), hungu c(6).

author information: 
(1)institute tropical medicine infectious diseases (itromid), po box
54840-00200, nairobi, kenya. chege.william@gmail.com.
(2)kenya medical research institute, centre biotechnology research and
development (kemri, cbrd), po box 54840-00200, nairobi, kenya.
chege.william@gmail.com.
(3)school health sciences, kirinyaga university college (constituent college
of jkuat), p.o. box 143-10300, kerugoya, kenya. lauranyawira@yahoo.com.
(4)kenya medical research institute, centre biotechnology research and
development (kemri, cbrd), po box 54840-00200, nairobi, kenya. elelo@kemri.org.
(5)kenya medical research institute, centre biotechnology research and
development (kemri, cbrd), po box 54840-00200, nairobi, kenya. fkimani@kemri.org.
(6)kenya medical research institute, centre biotechnology research and
development (kemri, cbrd), po box 54840-00200, nairobi, kenya.
charityhungu@gmail.com.

background: plasmodium falciparum resistance chloroquine (cq) denied
healthcare providers access cheap effective anti-malarial drug.
resistance proven due point mutations parasite's pfcrt
gene, particularly codon 76, resulting amino acid change lysine 
threonine. study sought determine prevalence pfcrt k76t
mutation 13 years cq cessation msambweni, kenya.
methods: finger-prick whole blood collected 3mm whatman(®) filter paper
from 99 falciparum malaria patients. parasite dna extracted via chelex
method individual blood spots used template nested pcr
amplification pfcrt. apo1 restriction enzyme used digest amplified 
dna identify samples wild type sensitive codon 76. prevalence
figures mutant pfcrt 76t gene calculated dividing number of
samples bearing mutant gene total number samples multiplied by
100 %. chi square tests used test significance findings
against previous prevalence figures.
results: 99 clinical samples collected 2013, prevalence mutant
pfcrt 76t gene stood 41 %.
conclusion: results indicate significant [χ(2) test, p ≤ 0.05 (2006 vs
2013)] reversal sensitivity p. falciparum population study site 
compared situation reported 2006 study site. could
primarily driven diminished use cq study area line the
official policy. studies establish prevalence pfcrt 76t gene could be
expanded countrywide establish cq sensitivity status predict date
when cq may re-introduced part malaria chemotherapy.

doi: 10.1186/s12936-015-0850-9 
pmcid: pmc4546357
pmid: 26296743  [indexed medline]

